Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert Robey
Pretreatment With DNA-damaging Agents Permits Selective Killing of Checkpoint-Deficient Cells by Microtubule-Active Drugs
Journal of Clinical Investigation
Medicine
Related publications
Sensitization of Cancer Cells to DNA Damaging Agents by Imidazolines
Activation of ATM by DNA Damaging Agents
Small-Molecule Inhibition of Wee1 Kinase by MK-1775 Selectively Sensitizes P53-Deficient Tumor Cells to DNA-damaging Agents
Molecular Cancer Therapeutics
Cancer Research
Oncology
Induction of RNA-binding Proteins in Mammalian Cells by DNA-damaging Agents.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Depletion of ATR Selectively Sensitizes ATM-deficient Human Mammary Epithelial Cells to Ionizing Radiation and DNA-damaging Agents
Cell Cycle
Medicine
Developmental Biology
Cell Biology
Molecular Biology
Combating Resistance to DNA Damaging Agents
Oncoscience
Cancer Research
Oncology
Pharmacological Inhibition of EZH2 Combined With DNA‑damaging Agents Interferes With the DNA Damage Response in MM Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Methods for Detecting DNA Damaging Agents in Humans
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Hyperactive End Joining Repair Mediates Resistance to DNA Damaging Therapy in P53-Deficient Cells